Playing with Patent Law: Profit Making Scheme

On June 13, 2013 Supreme Court of US ordered that naturally occurring genes and the information encoded by them will not be patented, though artificially synthesized ones can be. The issue came to picture when patent was filed by Myriad for BRCA 1 and BRCA2, which are human genes related to breast and ovarian cancer respectively. Myriad genetics is …